TD Asset Management
MNTA

TD Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

TD Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-93,385
Closed -$3.11M – 1426
2020
Q2 		$3.11M Buy
93,385
+4,200
+5% +$134K ﹤0.01% 771
2020
Q1 		$2.43M Buy
89,185
+4,400
+5% +$123K ﹤0.01% 786
2019
Q4 		$1.67M Buy
84,785
+8,101
+11% +$130K ﹤0.01% 967
2019
Q3 		$994K Buy
76,684
+4,300
+6% +$51.9K ﹤0.01% 1051
2019
Q2 		$901K Sell
72,384
-16,800
-19% -$223K ﹤0.01% 1068
2019
Q1 		$1.3M Sell
89,184
-1,300
-1% -$16.6K ﹤0.01% 993
2018
Q4 		$999K Buy
90,484
+41,484
+85% +$577K ﹤0.01% 1055
2018
Q3 		$1.29M Buy
+49,000
New +$1.32M ﹤0.01% 1100
2018
Q1 		– Sell
-13,500
Closed -$188K – 1387
2017
Q4 		$188K Buy
+13,500
New +$182K ﹤0.01% 1306
2016
Q1 		– Sell
-10,100
Closed -$150K – 1399
2015
Q4 		$150K Hold
10,100
– – ﹤0.01% 1327
2015
Q3 		$166K Sell
10,100
-73,300
-88% -$1.5M ﹤0.01% 1315
2015
Q2 		$1.9M Sell
83,400
-1,500
-2% -$29.9K ﹤0.01% 864
2015
Q1 		$1.29M Buy
+84,900
New +$1.1M ﹤0.01% 899
2014
Q2 		– Sell
-23,800
Closed -$277K – 1323
2014
Q1 		$277K Buy
23,800
+2,200
+10% +$37.3K ﹤0.01% 1171
2013
Q4 		$382K Hold
21,600
– – ﹤0.01% 1089
2013
Q3 		$311K Buy
21,600
+2,300
+12% +$35.2K ﹤0.01% 1101
2013
Q2 		$291K Buy
+19,300
New +$255K ﹤0.01% 1048

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

TD Asset Management's MNTA Position: Q3 2020 in Review

TD Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 93,385 shares — an estimated $3.11M sold.

TD Asset Management first reported a position in MNTA in Q2 2013 and held it in 17 quarters. The position peaked at $3.11M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • TD Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • TD Asset Management sold 93,385 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3.11M.
  • TD Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
  • TD Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $3.11M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on TD Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.